{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:00:24Z","timestamp":1762506024564,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.annfar.2012.10.024","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T22:45:31Z","timestamp":1357166731000},"page":"e43-e47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quoi de neuf en hyperthermie maligne en 2012\u00a0?"],"prefix":"10.1016","volume":"32","author":[{"given":"Y.","family":"Nivoche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dahmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2012.10.024_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","article-title":"Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group","volume":"105","author":"Glahn","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/003591577006300228","article-title":"Malignant hyperthermia","volume":"63","author":"Kalow","year":"1970","journal-title":"Proc Roy Soc Med"},{"key":"10.1016\/j.annfar.2012.10.024_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF03019094","article-title":"Anesthesiology, the birth of pharmacogenetics and Werner Kalow [editorial]","volume":"51","author":"Viby-Mogensen","year":"2004","journal-title":"Can J Anesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00424-010-0794-4","article-title":"Ryanodine receptors channelopathies","volume":"460","author":"Betzenhauser","year":"2010","journal-title":"Pflugers Arch\u00a0\u2013\u00a0Eur J Physiol"},{"key":"10.1016\/j.annfar.2012.10.024_bib0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-3565(25)11690-X","article-title":"The action of ryanodine on mammalian skeletal muscle in situ","volume":"117","author":"Procita","year":"1956","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.annfar.2012.10.024_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0031-6997(24)01313-9","article-title":"The pharmacology of ryanodine and related compounds","volume":"49","author":"Sutko","year":"1997","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.annfar.2012.10.024_bib0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/ane.0b013e3181a9d8d9","article-title":"The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia","volume":"109","author":"Capacchione","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2012.10.024_bib0040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/ALN.0b013e318232008f","article-title":"Nonanesthetic malignant hyperthermia [editorial]","volume":"115","author":"Lehmann-Horn","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0045","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1213\/ANE.0b013e318222af2e","article-title":"Future directions in malignant hyperthermia research and patient care","volume":"113","author":"Hirshey Dirksen","year":"2011","journal-title":"Anesth Analg"},{"issue":"5-C2","key":"10.1016\/j.annfar.2012.10.024_bib0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0035-3787(04)71008-5","article-title":"G\u00e9n\u00e9tique des pathologies associ\u00e9es \u00e0 un dysfonctionnement du complexe de mobilisation calcique du muscle squelettique","volume":"160","author":"Lunardi","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.annfar.2012.10.024_bib0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RyR1\u00a0in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.annfar.2012.10.024_bib0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1085\/jgp.200910328","article-title":"A malignant hyperthermia-inducing mutation in RyR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR","volume":"135","author":"Esteve","year":"2010","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.annfar.2012.10.024_bib0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm.2598","article-title":"AICAR prevents heat-induced sudden death in RyR1\u00a0mutant mice independent of AMPK activation","volume":"18","author":"Lanner","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.annfar.2012.10.024_bib0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ALN.0b013e318190bb08","article-title":"Trends and outcomes of malignant hyperthermia in the United States, 2000\u00a0to 2005","volume":"110","author":"Rosero","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0080","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1213\/ane.0b013e3181ac1548","article-title":"Prevalence of malignant hyperthermia due to anesthesia in New York state, 2001\u20132005","volume":"109","author":"Brady","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2012.10.024_bib0085","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment and complications of malignant hyperthermia in North America from 1987\u00a0to 2006","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2012.10.024_bib0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-6576.2011.02573.x","article-title":"The severity of sevoflurane-induced malignant hyperthermia","volume":"56","author":"Migita","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.annfar.2012.10.024_bib0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/bja\/aep108","article-title":"Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility","volume":"103","author":"Robinson","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0100","first-page":"390","article-title":"\u00c9pig\u00e9n\u00e9tique et d\u00e9veloppement\u00a0: l\u2019empreinte parentale","volume":"21","author":"Gabory","year":"2005","journal-title":"Med Sci"},{"key":"10.1016\/j.annfar.2012.10.024_bib0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0110","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading score to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/ALN.0b013e31818958e5","article-title":"Postoperative malignant hyperthermia","volume":"109","author":"Litman","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.anes.0000265144.63696.af","article-title":"Recrudescence of malignant hyperthermia [editorial]","volume":"106","author":"Hopkins","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/ALN.0b013e3181ee2cb7","article-title":"Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients. A review of past and present practice","volume":"114","author":"Kim","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1399-6576.2011.02506.x","article-title":"Washout of sevoflurane from the GE Avance and Amingo Carestation anesthetic machines","volume":"55","author":"Br\u00fcnner","year":"2011","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.annfar.2012.10.024_bib0140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/ALN.0b013e318223116c","article-title":"Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: when are they really clean [correspondence]","volume":"115","author":"Wappler","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2012.10.024_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1460-9592.2007.02302.x","article-title":"Duchenne muscular dystrophy: an old anesthesia problem revisited","volume":"18","author":"Hayes","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1460-9592.2006.02105.x","article-title":"The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder","volume":"17","author":"Flick","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/bja\/aeq036","article-title":"Anaesthesia and the sex-linked dystrophies: between a rock and a hard place [editorial]","volume":"104","author":"Hopkins","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1460-9592.2011.03649.x","article-title":"Excess comorbidities associated with malignant-hyperthermia diagnosis in pediatric hospital discharge records","volume":"19","author":"Li","year":"2011","journal-title":"Paediatr Anaesth"},{"issue":"S1","key":"10.1016\/j.annfar.2012.10.024_bib0165","doi-asserted-by":"crossref","first-page":"i79","DOI":"10.1093\/bja\/aer335","article-title":"Perioprative management of the paediatric patient with coexisting neuromuscular disease","volume":"107","author":"Lerman","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2012.10.024_bib0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ACO.0b013e3283393977","article-title":"Can inhalational agents be used in the presence of a child with myopathy?","volume":"23","author":"Veyckemans","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.annfar.2012.10.024_bib0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1213\/ANE.0b013e3182373b4a","article-title":"Creation of a guide for the transfert of care of the malignant hyperthermia patient from ambulatory surgery centers to receiving hospital facilities","volume":"114","author":"Larach","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2012.10.024_bib0180","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0310057X1103900514","article-title":"Safety of exposure of malignant hyperthermia non-susceptible patients and relatives to anaesthetic triggering agents","volume":"39","author":"Pollock","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.annfar.2012.10.024_bib0185","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1213\/ANE.0b013e318213fad7","article-title":"Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines","volume":"112","author":"Birgenheier","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2012.10.024_bib0190","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1213\/ANE.0b013e318215c56f","article-title":"Malignant hyperthermia and charcoal absorbent: too hot to handle [editorial]","volume":"112","author":"Block","year":"2011","journal-title":"Anesth Analg"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075076581200425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075076581200425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:17:32Z","timestamp":1760091452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075076581200425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S075076581200425X"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2012.10.024","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quoi de neuf en hyperthermie maligne en 2012\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2012.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}